摘要
目的探讨瑞舒伐他汀强化降脂对于缺血性脑卒中患者的治疗效果。方法以我院收治的120例缺血性脑卒中患者为研究对象,随机分为对照组和观察组。对照组服用10 mg的瑞舒伐他汀,观察组服用20 mg的瑞舒伐他汀,比较两组患者的治疗效果。结果治疗后,对照组患者的血脂水平以及颈动脉粥样硬化斑块面积分别为(4.93±0.52)mmol/L、(0.091±0.024)cm^2,观察组患者的血脂水平以及颈动脉粥样硬化斑块变化分别为(4.26±0.32)mmol/L、(0.075±0.012)cm2,差异具有统计学意义(t=8.500、4.619,P=0.000)。结论瑞舒伐他汀强化降脂的使用对于缺血性脑卒中患者有着明显效果。
Objective To investigate the efficacy of rosuvastatin for intensive lipid-lowering treatment efect in patients with ischemic stroke. Methods 120 cases of ischemic stroke patients in our hospital were selected as the research object and randomly divided into control group and observation group. The control group took 10 mg rosuvastatin, the observation group took 20 mg rosuvastatin, compared two groups of patients with treatment effect. Results After treatment, the control group of patients with blood lipid level and carotid atherosclerotic plaque were （4.93±0.52） mmol/L, （0.091±0.024） cm2, blood lipid level of observation group patients and carotid atherosclerotic plaque changes respectively （4.26±0.32） mmol/L, （0.075±0.012） cm2, the difference was statistically signifcant （t=8.500, 4.619, P=0.000）. Conclusion The use of rosuvastatin intensive lipid-lowering has obvious efect in ischemic stroke patients.
出处
《中国继续医学教育》
2017年第24期162-163,共2页
China Continuing Medical Education
